BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2777338)

  • 1. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
    Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
    Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
    Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
    Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
    Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
    Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
    Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
    Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
    Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
    Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
    Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
    Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
    Wan AM; Ennis P; Parham P; Holmes N
    J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel allele HLA-B*7805 in a Japanese female.
    Sekimoto T; Araseki M; Sato S; Sakaya S; Kato T; Ikeda H
    Tissue Antigens; 2001 Nov; 58(5):345-8. PubMed ID: 11844148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B locus DNA typing: detection of B*7801 and seven additional alleles by BW6-specific exon 2 amplification.
    Andrien M; Tiercy JM; Defleur V; Bouillenne C; Toungouz M; Jeannet M; Dupont E
    Tissue Antigens; 1993 Nov; 42(5):480-7. PubMed ID: 8146859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new HLA-B18 allele, B*1806, which lacks expression of the Bw6 epitope.
    Balas A; García-Sánchez F; Santos S; Lillo R; Merino JL; Vicario JL
    Tissue Antigens; 1998 Dec; 52(6):579-82. PubMed ID: 9894858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
    Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
    Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
    Lutz CT
    Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical importance of variation within the HLA-Bw4 complex.
    Collins RW; Harmer AW; Heads AJ; Kondeatis E; Page G; Vaughan RW
    Transplantation; 2001 Dec; 72(11):1851-3. PubMed ID: 11740403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, sequencing and serology of HLA-B*3527.
    Guttridge MG; Thompson J; Street J; Darke C
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):383-5. PubMed ID: 10323345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A public HLA antigen associated with HLA-A9, Aw32, and Bw4.
    Kostyu DD; Cresswell P; Amos DB
    Immunogenetics; 1980; 10(5):433-42. PubMed ID: 22457917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Bw4/Bw6 mismatch across class I HLA loci with renal graft outcomes in first time transplants.
    Tang MS; Wang M; Chang SH; Alhamad T; Liu C
    Hum Immunol; 2021 Oct; 82(10):767-774. PubMed ID: 34362574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
    Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
    J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.
    Sekimata M; Hayashi H; Nakayama S; Kano K; Takiguchi M
    Immunogenetics; 1989; 30(3):229-31. PubMed ID: 2476390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.